WBALTV, December 9, 2011. Experts said the new generation of birth control pills, like Yaz and Yasmine, contain a new type of hormone called drospirenone, and several studies have suggested that women who take these types of birth control pills have twice the risk for developing blood clots compared to those taking older forms of pills.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
FDA Panel Gives Tepid Okay to Birth Control Pill
Medpage Today, December 9, 2011. In a lukewarm endorsement, an FDA advisory panel voted 15-11 that the benefits of controversial drospirenone-containing oral contraceptives outweigh the risk of venous thromboembolism.
Read More »FDA Revokes Avastin Approval for Breast Cancer- Decision Leaves Some Devastated
The Washington Post, November 19, 2011. “The science is clear: Breast cancer patients are more likely to be harmed than helped by Avastin,” said Diana Zuckerman, president of the National Research Center for Women & Families. “The risks of the drug are very substantial and can be fatal, killing patients long before they would otherwise die from the disease. FDA made a scientific decision, and it was absolutely the right decision.”
Read More »FDA Revokes Approval of Avastin for Breast Cancer
Associated Press, November 18, 2011. Dr. Diana Zuckerman, tells AP about the problems with Avastin.
Read More »Lawmakers May Relax FDA Drug Conflict Rules
Reuters, November 1, 2011. Dr. Diana Zuckerman, president of the National Research Center for Women & Families, talks about the need for stronger conflict of interest rules for the FDA.
Read More »